*Recommended for FUTURE in Urology Program Students*
THURSDAY, SEPTEMBER 4, 2025
*7:00 am - 8:00 am
CONTINENTAL BREAKFAST
Grand Ballroom A+B
*8:00 am - 8:15 am
INTRODUCTION & WELCOME
Grand Ballroom C+D+E
Vernon Pais MD and Lane Palmer, MD
8:15 am - 9:30 am
SCIENTIFIC SESSION I: Oncology I
Grand Ballroom C+D+E
5 minute presentation, 2 minute discussion)
Moderators: Drew Wagner, MD and Stephen Ryan, MD
Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer
Zhiyu Qian, MD
1,Kevin Zhangxu, BA
2, Christopher J. Magnani, MD, MPhil, MS
1, Vincent D. Andrea, MD
1, Guilherme G. Barros, MD
3, Giuliano B. Guglielmetti, MD
3, Rafael F. Coelho, MD
3, Miguel A. Mestre, MD
4, Stephan Korn, MD
1, Hanna Zurl, MD
1, Klara Pohl, MD
1, Andrea Piccolini, MD
1, Matthew Mossanen, MD, MPH
1, Quoc-Dien Trinh, MD, MBA
5, Alexander P. Cole, MD
1, Adam S. Kibel, MD
1, Timothy N. Clinton, MD, MPH
1.
1Brigham and Women's Hospital, Boston, MA, USA,2Harvard Medical School, Boston, MA, USA,3Universidade de Sao Paulo, Sao Paulo, Brazil,4University Hospital of Son Espases, Mallorca, Spain,5University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Modeling survival outcomes of KEYNOTE-564 with standard of care control Arm treatment: A simulation study.
Fady Ghali, MD
1, Keervani Kandala, BS
1, Syed N. Rahman, MD
1, Spencer L. James, MD, MPH
2.
1Yale University School of Medicine, New Haven, CT, USA,2Docere.ai, Seattle,WA,USA.
Genomic Classifiers and Gleason Grade Group in Active Surveillance: Refining Risk Stratification in Prostate Cancer
Nethusan Sivanesan, BS, Gabriela M. Diaz, MD, Sebastian Strachan, MD, Darryl T. Martin, PhD, Peter S. Palencia, BS, Shayan Smani, BS, Wei S. Tan, MD,PhD, Isaac Y. Kim, MD, PhD, Micahel S. Leapman, MD, MHS, Preston C. Sprenkle, MD.
Yale School of Medicine, New Haven, CT, USA.
Staging Imaging Outcomes for Patients with Unfavorable Intermediate Risk Prostate Cancer Following Updates to the NCCN Guidelines
Ling Chi, BS
1, Dylan Buller, MD
2, Ilene Staff, PhD
3, Kevin Pinto, BS
3, Tara McLaughlin, PhD
3, Laura Olivo Valentin, BS
3, Joseph Tortora, MS
3, Andrew Salner, MD
4, Joseph Wagner, MD
4.
1University of Connecticut School of Medicine, Farmington, CT, USA,2UConn Health, Farmington, CT, USA,3Hartford Healthcare, Hartford, CT, USA,4Hartford Healthcare Medical Group, Hartford, CT, USA.
Modeling survival outcomes of CHECKMATE-274 with contemporary standard of care control-arm treatment: A simulation study
Keervani Kandala, BS
1, Syed N. Rahman, MD
2, Spencer L. James, MD, MPH
3,Fady Ghali, MD
2.
1Yale University School of Public Health, New Haven, CT, USA,2Yale University School of Medicine, New Haven, CT, USA,3Docere.ai, Seattle, WA, USA.
Multiparametric MRI screening for individuals at high risk of prostate cancer in the Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)
Aileen J. Feng, BA, Andrew E. Amini, MD, Himanshu Patankar, BS, Margaret R. O'Dea, CNP, Shelley R. McCormick, LCGC, Linda H. Rodgers-Fouche, LCGC, Keyan Salari, MD, PhD.
Massachusetts General Hospital, Boston, MA, USA.
Smoking is a Significant Risk Factor for Complications following Robotic Assisted Laparoscopic Radical Prostatectomy: A National Surgical Quality Improvement Program (NSQIP) Analysis
Jonathan J. Song, BA
1, Maya T. Zhou, BS
1, James McAndrew Jones, III, MD
2, Mark H. Katz, MD
2, David S. Wang, MD
2.
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA,2Boston Medical Center, Boston, MA, USA.
Impact of family history and germline genetic risk on biopsy upgrading in prostate cancer patients on active surveillance
Chandler Bronkema, MD, Preeti Chachlani, MA, Xiu Lui, MS, Aileen Feng, BS, Himanshu Patankar, BS, Andrew Gusev, MD, Chin-Lee Wu, MD, PhD, Jason Efstathiou, MD, DPhil, Richard Lee, MD, PhD, Anthony Zietman, MD, Douglas Dahl, MD, Michael Blute, MD, Adam Feldman, MD, MPH, Keyan Salari, MD, PhD.
Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
8:15 am - 9:30 pm
CONCURRENT POSTER SESSION I: Benign:
Commonwealth Ballroom C
(30 min viewing, 2-minute presentation, 2-minute discussion)
Moderators: Courtney Rowe, MD and E. Ann Gormley, MD
Urology Workforce Shortages: Increasing Transfer Burden on Tertiary Care Centers
Orleiquis Guerra, MD, Elisa Rocha, MD, Jennifer Fantasia, MD, Jennifer K. Yates, MD, Mitchell Sokoloff, MD.
University of Massachusetts, Worcester, MA, USA
Implementation of trict Pre-operative Selection Criteria for the Male Urethral Sling Results in Comparable Treatment Outcomes to the Artificial Urinary Sphincter
Philip Olson, MD
1, Avery Pollicita, BS
2, Ilene Staff, PhD
2, Kevin Pinto, BS
3, Tara McLaughlin Proto, PhD
3, Laura Olivo Valentin, BS
3, Joseph Tortora, MS
3, Richard Kershen, MD
3.
1UConn Health, Farmington, CT, USA2Hartford Hospital, Hartford, CT, USA3Hartford Healthcare, Hartford, CT, USA.
Evaluating the Appropriateness of Large Language Model Recommendations for Overactive Bladder Management
Architha Sudhakar, MD
1, Divya Ajay, MD, MPH
2, Sanchita Bose, MD
1.
1Maine Medical Center, Portland, ME, USA2Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
Renal pseudoaneurysm identification: a real-world sensitivity of pre-angiogram imaging
Anna Saltman, MD, MS
1,Samuel Iofel, BA
2, William Faust, MD
1.
1Lahey, Burlington, MA, USA2Tufts University School of Medicine, Boston, MA, USA.
Trends and Insights from Urology Residency Applicants: A Qualitative Analysis of Online Impressions (2022-2024)
Brielle Barclay-Rochefort, DPT, Katherine Merport, BA, Cedrick B. Chiu, BS, Luke Maietta, BA, Xinyue C. Tan, MD, Jennifer Fantasia, MD, Ashley Alford, MD.
UMass Chan Medical School, Worcester, MA, USA.
Pediatric Circumcision and Spinal Anesthesia: Fast, Effective, and Cheap
Adam Cole, MD, Emma Harwood, MD, Evelyn James, MPH, David Chalmers, MD, Lily C. Wang, MD, PhD.
Maine Medical Center, Portland, ME, USA.
Reoperation Risk in Distal Hypospadias: A Multicenter Study Utilizing the Live TriNetX Claims Database
Angelina Kuzina, B.S.
1, Richard Grunert, M.D.
1, Mohammad Mohaghegh, M.D.
1, Gerald Mingin, M.D.
1, Sarah Kohl, B.S.
1, Benjamin Rubin, B.S.
1, Jacob Bleau, B.S.
1, Nicholas Khoo, B.S.
1, Daehee Jeong, B.A.
2.
1The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, USA2Washington University School of Medicine, St. Louis, MO, USA.
Cumulative Antibiotic Exposure in the Pediatric Spina Bifida Population
Than S. Kyaw, MD, PhD
1, Debbie Goldberg, MS
2, Lindsay Hampson, MD, MAS
2, Hillary Copp, MD, MS
2.
1Massachusetts General Brigham, Boston, MA, USA2University of California San Francisco, San Francisco, CA, USA.
Socioeconomic Status and Mortality in Fournier's Gangrene
Emma Laquinta, BA
1, Allegra Rollo, BA
1, Aaron M. Seto, BA
1, Taylor Braunagel, MS
1, Kamil Malshy, MD
2, Madeline Cancian, MD
1.
1The Minimally Invasive Urology Institute, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA2University of Rochester Medical Center, Rochester, NY, USA.
Evaluating Evolving Treatment Pathways for Interstitial Cystitis/ Bladder Pain Syndrome (IC/BPS) Utilizing Multi-Institutional Data from TriNetX
Cedrick B. Chiu, BS
1,Benjamin E. Rubin, BS
2, Jennifer Anger, MD, MPH
3.
1UMass Chan Medical School, Worcester, MA, USA2University of Vermont, Burlington, VT, USA3UC San Diego Medical Center, La Jolla, CA, USA
Do equivalent settings produce equivalent research output? Gender Disparities in Research Among Urology Residents.
Juliana Villanueva Congote, MD, MPH
1, Michal Segall, MD
2, Christina Kottooran, MD
1, Brian H. Eisner, MD
1, Jessica E. Kreshover, MD
1.
1Massachussets General Hospital, Boston, MA, USA2Albert Einstein College of Medicine, New York, NY, USA.
*9:30 am - 10:00 am
PANEL: Trauma Recon: Contemporary Management of Urethral Stricture Disease: "A cause for OPTI-mism?"
Grand Ballroom C+D+E
Moderators:Jaime Cavallo, MD
Panelists: Jeremy Myers, MD, Alex Vanni MD, Will Boysen MD
*10:00 am - 10:30 am
COFFEE BREAK
Grand Ballroom A+B
10:30 am - 12:00 pm
CONCURRENT SCIENTIFIC SESSION II: Trauma, Recon, Female Urology and Transgender
Grand Ballroom C+D+E
Recon, Female Urology and Transgender
(5 minute presentation, 2-minute discussion)
Moderators: Khushabu Kasabwala, MD and Joshua Sterling, MD
Impact of Vaginal Estrogen on Serious Adverse Outcomes in Postmenopausal Women with Recurrent Urinary Tract Infections: A Retrospective Study
Brennan Wells, Bachelor of Science
1, Joseph Visingardi, PharmD
2, Elise JB De, MD
2, Paul J. Feustel, MEng, PhD
2.
1Eastern Virginia Medical School, Norfolk, VA, USA2Albany Medical College, Albany, NY, USA
Frailty as a Continuous Predictor of Postoperative Outcomes Following Midurethral Sling Surgery
Rachel C. Bernardo, BS
1, Meredith C. Wasserman, MD
2.
1The George Washington University School of Medicine and Health Sciences, Washington, DC, USA2Division of Urology, Department of Surgery, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Urologic outcomes following abdominoperineal resection: a multi-institutional analysis
Sami Wilder, MD
1, Anna Saltman, MD, MS
2,Brielle Barclay-Rochefort, DPT
2, Andrew Mizerowski, BA
1, Michael Callegari, MD, MBA
2, Caroline Kreytak, BA
2, Mateo Mora, MD
1, Logan Hubbard, MD
1, Nabeel Shakir, MD
1, Alex Vanni, MD
2, Marcus Jamil, MD
1.
1Henry Ford, Detroit, MI, USA2Lahey, Burlington, MA, USA.
Do Reproductive Surgeons and Other Physicians Differentiate Anatomy and Gender Identity?
Andrew Shin, BS
1, Jennifer Howell, PhD
2, Martin Kathrins, MD
3, Brian O'Shea, PhD
4, Alex Keuroghlian, MD
3, Bianca Hinojosa, PhD
5, William Meese, PhD
2, William Boysen, MD
3.
1Harvard Medical School, Boston, MA, USA2University of California, Merced, Merced, CA, USA3Mass General Brigham, Boston, MA, USA4University of Nottingham, Nottingham, United Kingdom5San Jose State University, San Jose, CA, USA.
Management of distal Neovaginoplasty stricture with bilateral labia minora Singapore fascio-cutaneous flaps
Nicolas Munarriz, BA,Laura Maciejko, MD, Jaromir Slama, MD, Robert Oates, MD, Ricardo Munarriz, MD.
Boston Medical Center, Boston, MA, USA
Diabetes is Associated ith Better Short-Term Survival in Fournier's Gangrene
Aaron Seto, BA
1, Emma Laquinta, BA
1, Kamil Malshy, MD
2, Allegra Rollo, BA
1, Taylor Braunagel, BS, MS
1, Richard Glebocki, BS
1, Borivoj Golijanin, MD
1, Madeline Cancian, MD
1.
1The Minimally Invasive Urology Institute at the Miriam Hospital, Brown University Health, Warren Alpert Medical School of Brown University, Providence, RI, USA,2University of Rochester Medical Center, Rochester, NY, USA.
Immediate and Long-Term Hematuria Outcomes in Patients with Mild to Moderate Radiation Cystitis Treated with Hyperbaric Oxygen Therapy: A retrospective analysis
Allison G. Booher, B.A.
1,Kathryn McGonagle, B.S.
1, Janet Peacock, PhD
1, Elaine Silverman, M.D.
2, Pamela Hannigan, M.D.
2, Lawrence Bornt, R.N.
2, William Bihrle, III, M.D.
2, Jay Buckey, Jr., M.D.
2, Rachel Moses, M.D., M.P.H.
2.
1Geisel School of Medicine at Dartmouth College, Hanover, NH, USA2Dartmouth Health, Lebanon, NH, USA.
Open Transplant Ureteral Reconstruction: A Single Institution Experience
Ankur Ushir Choksi, MD
1, Sanjay Kulkarni, MD
2, John W. Colberg, MD
1.
1Department of Urology, Yale School of Medicine, New Haven, CT, USA2Division of Transplant and Immunology, Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
Long-term Outcomes of Conservative Management for Lichen Sclerosus Urethral Stricture Disease
Anna J. Saltman, MD, MS, Michael Callegari, MD, MBA, Tasneem Z. Rizvi, PhD, Alex J. Vanni, MD.
Lahey, Burlington, MA, USA.
The Optilume® Drug Coated Balloon for recurrent anterior urethral strictures: ROBUST III study 4-year results
Sean Elliott, MD
1,Karl Coutinho, MD
2, Kaiser Robertson, MD
3, Richard D'Anna, MD
4, Kent Chevli, MD
5, Serge Carrier, MD
6, Melanie Aube-Peterkin, MD
6, Christopher H. Cantrill, MD
7, Michael J. Ehlert, MD
8, Alexis E. Te, MD
9.
1University of Minnesota, Minneapolis, MN, USA2Summit Medical Group, Millburn, NJ, USA3Chesapeake Urology, Hanover, MD, USA4Arkansas Urology, Little Rock, AR, USA5Western New York Urology Associates, Cheektowaga, NY, USA6McGill University Health Center, Montreal, QC, Canada7Urology San Antonio, San Antonio, TX, USA8Metro Urology, Woodbury, MN, USA9Weill Cornell Medicine, New York, NY, USA.
10:30 am - 12:00 pm
CONCURRENT POSTER SESSION II: Oncology I
Commonwealth Ballroom C
(30 min viewing, 2-min presentation, 2-min discussion)
Moderators: Matthew Clements, MD and Jeffrey Howard, MD
The Role of SHP1 as a Tumor Suppressor in Bladder Cancer Cell Lines
Shannon McNall, MD, Daniel Pohl, MD, Kailey Hooper, BS, Travis Sullivan, MS, Kimberly Rieger-Christ, PhD.
Lahey Hospital and Medical Center, Burlington, MA, USA.
Machine Learning Approaches to Optimize the Integration of Sociodemographic Factors in the Prediction of Cancer-Specific Survival Among Patients with High-Risk Prostate Cancer
Ismail Ajjawi, BS
1, Isaac E. Kim, BS
2, Shayan Smani, BS
1, Peter Palencia, MD
1, Gabriela M. Diaz, MD
1, Ho-Joon Lee, MD
1, Isaac Y. Kim, MD
1, Preston Sprenkle, MD
1, Michael S. Leapman, MD
1.
1Yale School of Medicine, New Haven, CT, USA2The Warren Alpert Medical School of Brown University, Providence, RI, USA.
TAR-200 monotherapy in patients with bacillus Calmette-Guérin-unresponsive papillary disease-only high-risk non-muscle-invasive bladder cancer: first results from Cohort 4 of SunRISe-1
Félix Guerrero-Ramos, MD, PhD
1, Joseph M. Jacob, MD
2, Michiel S. Van der Heijden, MD, PhD
3, Martin Bögemann, MD
4, Siamak Daneshmand, MD
5, Andrea Necchi, MD
6, Daniel Zainfeld, MD
7, Philipp Spiegelhalder, MD
8, Evanguelos Xylinas, MD
9, David Cahn, MD
10, Yair Lotan, MD
11,Katie S. Murray, DO
12, Takashi Kawahara, MD, PhD
13, Katharine Stromberg, PhD
14, Jason Martin, PhD
15, Abhijit Shukla, PhD
16, Christopher J. Cutie, MD
16, Shalaka Hampras, PhD
14, Hussein Sweiti, MD
17, Giuseppe Simone, MD, PhD
18.
1Hospital Universitario 12 de Octubre, Madrid, Spain2Upstate Medical University, Syracuse, NY, USA3Netherlands Cancer Institute, Amsterdam, Netherlands4Münster University Hospital, Münster, Germany5University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA6IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy7Urology San Antonio, San Antonio, TX, USA8Urologie Neandertal, Gemeinschaftspraxis für Urologie, Mettmann, Germany9Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France10Colorado Urology, Lakewood, CO, USA11UT Southwestern Medical Center, Dallas, TX, USA12NYU Langone Health, New York, NY, USA13Yokohama City University Medical Center, Yokohama, Japan14Johnson & Johnson, Raritan, NJ, USA15Johnson & Johnson, High Wycombe, United Kingdom16Johnson & Johnson, Lexington, MA, USA17Johnson & Johnson, Spring House, PA, USA18'Regina Elena' National Cancer Institute, Rome, Italy.
Preliminary results from LEGEND: a Phase 2 study of detalimogene voraplasmid, a novel, investigational, non-viral genetic medicine for high-risk non-muscle invasive bladder cancer (NMIBC)
Mark Preston, MD
1, John A. Taylor, MD
2, Ashish M. Kamat, MD
3, Suzanne Merrill, MD
4, Sam S. Chang, MD
5, Vignesh T. Packiam, MD
6, Shreyas Joshi, MD
7, Jen-Jane Liu, MD
8, Ricardo Rendon, MD
9, Wassim Kassouf, MD
10, Jeff Holzbeierlein, MD
2, Mark Tyson, MD
11, Rian Dickstein, MD
12, Raj Satkunasivam, MD
13, Neal Shore, MD
14, Amy N. Luckenbaugh, MD
5, Alberto Martini, MD
15, Raj Pruthi, MD
16, Katherine Chan, MD
16, Anthony Cheung, MD
17, Christine Tosone, MD
16, Yair Lotan, MD
18.
1Brigham and Women's Hospital, Boston, MA, USA, 2University of Kansas Cancer Center, Kansas City, KS, USA, 3University of Texas MD Anderson Cancer Center, Houston, TX, USA, 4Colorado Urology, Brighton, CO, USA, 5Vanderbilt University, Nashville, TN, USA, 6Rutgers RWJ Barnabas Health, West Orange, NJ, USA, 7Emory University School of Medicine, Atlanta, GA, USA, 8Oregon Health Science University, Portland, OR, USA, 9Dalhousie University, Halifax, NS, Canada, 10McGill University, Montreal, QC, Canada, 11Mayo Clinic, Phoenix, AZ, USA, 12Chesapeake Urology, Hanover, MD, USA, 13Houston Methodist-Weill Cornell Medical College, Houston, TX, USA, 14Carolina Urology Research Center, Myrtle Beach, SC, USA, 15University of Cincinnati Cancer Center, Cincinnati, OH, USA, 16enGene Inc.,, Waltham, MA, USA, 17enGene Inc. St-Laurent, QC, Canada, 18University of Texas Southwestern Medical Center, Dallas, TX, USA.
Contemporary Outcomes and Disease Burden of High-Grade T1 Bladder Cancer
Agustin Perez-Londono, MD.
1, Sumedh Kaul, MS
1, Aaron Fleishman, MPH
1, Ruslan Korets, MD
1, Heidi Rayala, MD, PhD
1, Peter Chang, MD, MPH
1, Andrew Wagner, MD
1, Joaquim Bellmunt, MD, PhD
2, Aria F. Olumi, MD
1, Boris Gershman, MD
1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA2Dana-Farber Cancer Institute, Boston, MA, USA.
Center-based endophycity measurement improves interobserver agreement of the RENAL nephrometry score
Clara E. Goebel, MS
31, Keenan Moore, MS
42, Nicholas Heller, PhD
3, Jayant Siva, BS/MD Student
3, Jamee Schoephoerster, MD
4, Griffin Struyk, MD
5, Nitin Venkatesh, MD
6, Beatriz Lopez Morato, Medicral Student
7, Christopher Weight, MD
3.
1University of Vermont Larner College of Medicine, Burlington, VT, USA2Loyola University Chicago, Maywood, IL, USA3Cleveland Clinic, Cleveland, OH, USA4Oregon Health & Science University, Portland, OR, USA5HealthPartners Regions Hospital, St Paul, MN, USA6Oakland University, Auburn Hills, MI, USA7Autonomous University of Madrid, Madrid, Spain.
Real-World Outcomes of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer inOlder Adults
Piroz Bahar, B.A.
1, Agustin Perez, M.D.
2, Sumedh Kaul, MS
2, Jason Efstathiou, MD
3, Stephen Williams, MD
4, Yong Shan, PhD
4, Peter Chang, MD
2, Andrew Wagner, MD
2, Aaron Fleishman, MPH
2, Aria Olumi, MD
2, Boris Gershman, MD
2.
1University of Michigan Medical School, Ann Arbor, MI, USA2Beth Israel Deaconess Medical Center, Boston, MA, USA3Massachusetts General Hospital, Boston, MA, USA4University of Texas Medical Branch, Galveston, TX, USA.
Bcg efficacy and disease survival are unaffected by prior pelvic radiation in high-grade t1 bladder cancer patients
Richard Glebocki, ScB, Raymond Che, MPH, Borivoj Golijanin, MD, Jack Mulcrone, BS, Sari Khaleel, MD, Dragan Golijanin, MD.
The Minimally Invasive Urology Institute at the Miriam Hospital, Brown University Health, Legoretta Cancer Center, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Evaluating The Therapeutic Role of Lymph Node Dissection in Variant Subtype Bladder Cancer
Syed N. Rahman, MD
1, Darryl Martin, MD
1, Wei Shen Tan, MD
1, David Hesse, MD
1, Peter Humphrey, MD
1, Jonathan Wright, MD
2, Sunil Patel, MD
3, Fed Ghali, MD
1.
1Yale School of Medicine, New Haven, CT, USA2University of Washington, Seattle, WA, USA3Johns Hopkins School of Medicine, Baltimore, MD, USA.
Comparative Analysis of PI-RADS and PI-FAB Scoring Systems in Post-Focal Therapy Assessment of Clinically Significant Prostate Cancer
Nethusan Sivanesan, BS, Gabriela M. Diaz, MD, Wei S. Tan, MD, PhD, Sandeep Arora, MBBS, Preston C. Sprenkle, MD.
Yale School of Medicine, New Haven, CT, USA.
Baseline frailty, treatment intensity, and clinical outcomes among older adults with locally advanced prostate cancer
Agustin Perez-Londono, MD., Sumedh Kaul, MS, Aaron Fleishman, MPH, Ruslan Korets, MD, Peter Chang, MD, MPH, Andrew Wagner, MD, Aria Olumi, MD, Marc Garnick, MD, Boris Gershman, MD.
Beth Israel Deaconess Medical Center, Boston MA, MA, USA.
Trends and Disparities in mpMRI Utilization for Patients with Newly Elevated PSA Levels from 2019-2023: An Analysis of Medicare Data
Hanna Zurl, MD
1, Klara K. Pohl, MD
1, Stephan M. Korn, MD
2, Nathaniel Hansen, MD
3, Zhiyu Qian, MD
3, Andrea Piccolini, MD
2, Jianyi Zhang, PhD, MS
2, Marianne Leitsmann, MD MHBA
4, Sascha Ahyai, MD
4, Quoc-Dien Trinh, MD MBA
5, Alexander P. Cole, MD
2.
1Center for Surgery and Public Health, Brigham and Women's Hospital and Medical University of Graz, Boston, MA, USA2Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA3Brigham and Women's Hospital, Boston, MA, USA4Medical University of Graz, Graz, Austria5University of Pittsburgh, Pittsburgh, PA, USA.
Association of Perirectal Spacer Use with Complications and Hospital Admission Rates after Prostate Radiotherapy
Peter S. Palencia, BS
1, Xiangyi Xi, PhD, MS
2, Xiwen Zhao, MS
2, Shayan Smani, BS
1, Nethusan Sivanesan, BS
1, Gabriela M. Diaz, MD
1, Marcin Miszyck, MD, PhD
3, Tamas Fazekas, MD
3, Pawel Rajwa, MD, PhD
3, Jaime Cavallo, MD, MPHS
1, Sanjay Aneja, MD
4, Yi An, MD
4, Isaac Y. Kim, MD, PhD
1, Michael S. Leapman, MD, MSPH
1.
1Department of Urology, Yale School of Medicine, New Haven, CT, USA2Yale Center for Analytical Sciences, Yale University, New Haven, CT, USA3Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria4Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
Association of Social and Emotional Support with Mental Health Outcomes Among Prostate Cancer Survivors: A Nationally Representative Analysis of 2023 BRFSS Data.
Jose I. Nolazco, MD, MMSc
1, Juliana Villannueva-Congote, MD
1, Zhiyu (Jason) Qian, MD
1, Muhieddine Labban, MD
1, Christopher P. Dall, MD
1, Federico Lavagno, MD
2, Eugene Chen, BA
3, Guilherme Garcia Barros, MD
4, Matthew Mossanen, MD, MPH
1, Aaron H. Lay, MD
1, Timothy N. Clinton, MD
1, Adam S. Feldman, MD, MPH
1, Steven L. Chang, MD, MS
1.
1Mass General Brigham, Boston, MA, USA2University of Turin, Turin, Italy3Medical College of Wisconsin, Milwaukee, WI, USA4University of São Paulo, São Paulo, Brazil.
*12:00 pm - 12:30 pm
STATE OF THE ART LECTURE I: "Managing radiation complications"
Grand Ballroom C+D+E
"Managing radiation complications"
Speaker: Jeremy Myers, MD
*12:30 pm - 12:45 pm
AMERICAN BOARD OF UROLOGY UPDATE
Grand Ballroom C+D+E
E. Ann Gormley, MD
*12:45 pm - 1:00 pm
SES Updates: PPC / SAC
Grand Ballroom C+D+E
Brian Irwin, MD and Jennifer Yates, MD
*1:00 pm - 2:00 pm
LUNCH SYMPOSIUM: "Initial and Updated Clinical Data for Certain Patients With RCC in the Adjuvant Setting"
Speaker: Paul R. Sieber, MD, Keystone Urology Specialists in Lancaster, PA.
Supported by Merck
Grand Ballroom C+D+E
LUNCH SYMPOSIUM: "CLINICAL INSIGHTS and the Evolving Role of NUBEQA® (darolutamide) in mCSPC"
Speaker: Murilo de Almeida Luz, MD, Urologic Oncologist (Clinical Instructor) at Mount Sinai Icahn Medical School
Supported by Bayer
Commonwealth Ballroom A+B
*2:00 pm - 2:30 pm
POSTER VIEWING TIME
Grand Ballroom Foyer
2:30 pm - 3:30
CONCURRENT POSTER SESSION III: Oncology II
Commonwealth Ballroom C
(2-min presentation, 2-min discussion)
Moderators: Timothy Clinton, MD and Anoop Meraney, MD
Mechanism of action and translation to the clinic of detalimogene voraplasmid- a novel, investigational, non-viral genetic medicine for non-muscle-invasive bladder cancer (NMIBC)
Mark Preston, MD
1, Raj? Satkunasivam, MD
2, Yair Lotan, MD
3, Suzanne Merrill, MD
4, Ashish M. Kamat, MD
5, Vignesh T. Packiam, MD
6, Shreyas Joshi, MD
7, Sam S. Chang, MD
8, Wassim Kassouf, MD
9, Jen-Jane Liu, MD
10, Mark Tyson, MD
11, Rian Dickstein, MD
12, Neal Shore, MD
13, Amy N. Luckenbaugh, MD
8, Alberto Martini, MD
14, Shauna Dauphinee, MD
15, Daniel Veilleux, MD
15, Carlos Fleet, MD
15, Raj Pruthi, MD
16, Kate Chan, MD
16, Anthony Cheung, MD
15, Vikram Narayan, MD
7.
1Brigham and Women's Hospital, Boston, MA, USA2Houston Methodist-Weill Cornell Medical College, Houston, TX, USA3University of Texas Southwestern Medical Center, Dallas, TX, USA4Colorado Urology, Brighton, CO, USA5University of Texas MD Anderson Cancer Center, Houston, TX, USA6Rutgers RWJ Barnabas Health, West Orange, NJ, USA7Emory University School of Medicine, Atlanta, GA, USA8Vanderbilt University, Nashville, TN, USA9McGill University, Montreal, QC, Canada10Oregon Health Science University, Portland, OR, USA11Mayo Clinic, Phoenix, AZ, USA12Chesapeake Urology, Hanover, MD, USA13Carolina Urology Research Center, Myrtle Beach, SC, USA14University of Cincinnati Cancer Center, Cincinnati, OH, USA15enGene Inc., St-Laurent, QC, Canada16enGene Inc., Waltham, MA, USA.
Does ureteroeneteric anastomosis stenting for radical cystectomy reduce ureteral stricture?
Muhieddine Labban, MD
1, Nathaniel F. Hansen, MD
1, Guilherme Garcia Barros, MD
2, Zhiyu (Jason) Qian, MD
1, Nnamdi Onochie, BS
1, Christopher Magnani, MD
1, Christopher P. Dall, MD
1, Jose Nolazco, MD
1, Mark A. Preston, MD, MPH
1, Matthew Mossanen, MD, MPH
1, Timothy N. Clinton, MD
1.
1Brigham and Women's Hospital, BOSTON, MA, USA, 2University of São Paulo, São Paulo, Brazil.
Accelerated biological aging with bladder and kidney cancer compared to prostate cancer or non-cancer controls: A UK Biobank study
Heather McClure, BS
1, Alison Kim, MPH
1, Shanshu Zhao, BS
2, George A. Kuchel, MD
3, Chia-Ling Kuo, PhD
3,Benjamin T. Ristau, MD, MHA
4.
1University of Connecticut School of Medicine, Farmington, CT, USA2University of Connecticut Graduate School, Farmington, CT, USA3UConn Health Center on Aging, Farmington, CT, USA4UConn Health, Farmington, CT, USA.
ERAS and Beyond: Optimizing Radical Cystectomy Outcomes with Modified ERAS
Adam Cole, MD
1, Joshua Linscott, MD, PhD
2, Connor Pelletier, BS
3, Evelyn James, MPH
1, Erin Santos, PA, MPH
1, Jeffrey Howard, MD, PhD
1, Stephen Ryan, MD
1, Matthew Hayn, MD
1, Jesse Sammon, DO
1, Randie White, MD
1.
1Maine Medical Center, Portland, ME, USA2Moffitt Cancer Center, Tampa, FL, USA3University of New England, Portland, ME, USA.
Contemporary Outcomes of Repeat Transurethral Resection among Patients with Non-Muscle Invasive Urothelial Carcinoma of the Bladder
Agustin Perez-Londono, MD
1, Sumedh Kaul, MS
1, Aaron Fleishman, MPH
1, Ruslan Korets, MD
1, Heidi Rayala, MD, PhD
1, Peter Chang, MD, MPH
1, Andrew Wagner, MD
1, Joaquim Bellmunt, MD, PhD
2, Aria F. Olumi, MD
1, Boris Gershman, MD
1.
1Beth Israel Deaconess Medical Center, Boston, MA, USA2Dana-Farber Cancer Institute, Boston, MA, USA.
Neoadjuvant Chemotherapy and Wound Healing Complications Following Radical Cystectomy for Muscle-Invasive Bladder Cancer
Emma A. Harwood, MD
1, Randie E. White, MS, MD
1, Evelyn James, MPH
1, Joshua A. Linscott, MD, PhD
2, Matthew T. Hayn, MD
1, Jesse D. Sammon, DO
1, Jeffrey M. Howard, MD, PhD
1, Stephen T. Ryan, MD
1.
1Maine Medical Center, Portland, ME, USA2Moffitt Cancer Center, Tampa, FL, USA.
Automated Abstraction Algorithm for Radical Cystectomy Surgical Outcomes
Peter S. Palencia, BS
1, Maximilian Rabil, MD
1, Michael Jalfon, MD
1, Dylan Heckscher, MD
1, Rhys Richmond, BS
2, Victoria Kong, BS
2, Aleksandra Golos, BS
2, Adam Chess, MPH
2, Michael S. Leapman, MD, MSHS
1, Jaime A. Cavallo, MD, MSHS
1.
1Department of Urology, Yale School of Medicine, New Haven, CT, USA2Yale University School of Medicine, New Haven, CT, USA.
Readmissions and complications after same day discharge following robot-assisted laparoscopic prostatectomy in Iceland: A nationwide population-based study
Hjalti R. Snorrason, BSc.
1,Edward Rumba, BSc.
1, Helgi K. Engilbertsson, MD.
2, Rafn Hilmarsson, MD.
2, Johann P. Ingimarsson, MD.
2.
1University of Iceland, Reykjavík, Iceland2Landspitali - The National University Hospital of Iceland, Reykjavík, Iceland.
MRI after HIFU Treatment is not a Reliable Determinant for Clinically Significant Prostate Cancer
Ignacio San Francisco, MD, Ra'ad Al-Faouri, MD, MMSc,Agustin Perez-Londono, MD., Andrew A. Wagner, MD, Peter Chang, MD, MPH, Boris Gershman, MD, Aria F. Olumi, MD.
Beth Israel Deaconess Medical Center, Boston MA, MA, USA.
Modulation of enhancer of zeste homolog 2 (EZH2) pharmacodynamic markers and tumor gene expression by mevrometostat plus enzalutamide in patients with castration-resistant prostate cancer (CRPC)
Michael Thomas Schweizer, MD
1, Li Liu, PhD
2, Szu-Yu Tang, PhD
2, Whijae Roh, PhD
2, Vinicius Bonato, PhD
2, Joan Carles, MD, PhD
3, Benjamin Garmezy, MD
4, Curtis J. Dunshee, MD, FACS
5, Guillermo de Velasco, MD, PhD
6, Konstantin Penkov, MD
7, Claudia Andreu-Vieyra, PhD
8, Neelesh Soman, MD, PhD
9, Begoña Mellado, MD, PhD
10.
1Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA2Pfizer Inc., San Diego, CA, USA3Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain4Sarah Cannon Research Institute, Nashville, TN, USA5Arizona Urology Specialists, Tucson, AZ, USA6Hospital Universitario 12 de Octubre, Madrid, Spain7General Department, Private Medical Institution "Euromedservice", St Petersburg, Russian Federation8Pfizer Inc., Collegeville, PA, USA9Pfizer Inc., Los Angeles, CA, USA10Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.
Associations Between Social Vulnerability and Metastatic Prostate Cancer at Diagnosis from 2018-2023 in Rhode Islan
Angelo Blancaflor, BS
1, Tim Wynter, BS
1, Borivoj Golijanin, MD
2, Natalia Alzate, BS
2, Taylor Braunagel, MS
2, Elias Hyams, MD
2.
1The Warren Alpert Medical School of Brown University, Providence, RI, USA2Brown University Health, Minimally Invasive Urology Institute, Providence, RI, USA.
Recidivism in Patients with Advanced vs. Localized Prostate Cancer: Elucidating Causes to Reduce Emergency Room Burden
William Connolly, BA, MSF
1, Alexandra Lee, BS
1, Owen Charles Phelps, BS
2, Shriya Perati, BS
1, Javier Prieto, BS
1, Angelo Blancafor, BS
1, Leah McDonald, MD
3, Elias Hyams, MD
3.
1Brown University, Providence, RI, USA2Mercer University, Macon, GA, USA3Brown University Health, Providence, RI, USA.
Socioeconomic disadvantage is associated with prostate cancer diagnosis and severity in the state of Rhode Island: A study of neighborhood-based variation
Angelo Blancaflor, BS
1, Tim Wynter, BS
1, Borivoj Golijanin, MD
2, Natalia Alzate, BS
2, Taylor Braunagel, MS
2, Elias Hyams, MD
2.
1The Warren Alpert Medical School of Brown University, Providence, RI, USA2Brown University Health, Minimally Invasive Urology Institute, Providence, RI, USA.
MRI Fusion Biopsy Era: Perineural Invasion Not Associated with Upgrading in Low-Risk Prostate Cancer
Nethusan Sivanesan, BS, Gabriela M. Diaz, MD, Sebastian Strachan, MD, Keervani Kandala, BS, Xiwen Zhao, MSPH, Wei S. Tan, MD PhD, Michael S. Leapman, MD, MHS, Preston C. Sprenkle, MD.
Yale School of Medicine, New Haven, NC, USA.
Penelope: tissue penetration of gemcitabine phosphate metabolites following TAR-200 administration vs standard intravesical instillation in minipigs
David Cahn, MD1, Siamak Daneshmand, MD
2, Koen Wuyts, BS
3, Marc De Meulder, BS
3, Liesbeth Vereyken, BS
3, Marjolein van Heerden, DVM
3, Herman Borghys, DVM
3, Geert Mannens, PhD
3, Karen Daniel, PhD
4, Samuel Spigelman, MD
5.
1Colorado Urology, Lakewood, CO, USA, 2University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA, 3Janssen Research & Development, Beerse, Belgium, 4Janssen Research & Development, Lexington, MA, USA, 5Janssen Research & Development, Raritan, NJ, USA.
2:30 pm - 3:30 pm
CONCURRENT SCIENTIFIC SESSION III: BPH/General/Best Practice
Grand Ballroom C+D+E
(5 minute presentation, 2-minute discussion)
Moderators: Michael Grant, MD and Jessica Mandeville, MD
Predicting the Durability of Selective Median Lobe Holmium Laser Enucleation of the Prostate: A Retrospective Cohort Study
Julien DuBois, BSPH, Mursal Gardezi, MD, Jason Lee, MD, Daniel Kellner, MD.
Yale School of Medicine, New Haven, CT, USA.
SRD5A2 Expression Correlates with Prostate Volume
Christina Sharkey, M.S., Nicolas Patsatzis, B.S., Xingbo Long, M.D., Ra'ad Alfaouri, M.D., Boqing Gu, Ph.D., Yao Tang, M.S., Victoria Faustin, M.S., Heidi J Rayala, M.D., Ruslan Korets, M.D., Boris Gershman, M.D., Zongwei Wang, Ph.D., Aria F Olumi, M.D..
Beth Israel Deaconess Medical Center, Brookline, MA, USA.
Attitudes Towards Ambient Artificial Intelligence Scribes in an Academic Urology Practice
Sharath Reddy, MD, Aleksandra M. Golos, BS, Mursal Gardezi, MD, Thomas V. Martin, MD, Marianne Casilla-Lennon, MD.
Yale School of Medicine Department of Urology, New Haven, CT, USA.
Immediate Release of Prostate Biopsy Test Results - Provider Experiences with the 21st Century Cures Act
Anna M. Ochsner, MD, Angelo Blancaflor, BS, Vikas Bhatt, MD MPH, Taylor Braunagel, MS, Liam Connolly, BS, Andrew Tompkins, MD, Elias Hyams, MD.
Brown University Health, Minimally Invasive Urology Institute, Providence, RI, USA.
The Phase 3 Open-Label COURAGE Extension Study to Evaluate the Long-Term Safety and Efficacy of Vibegron in Men With Overactive Bladder Symptoms on Pharmacotherapy for Benign Prostatic Hyperplasia
David R. Staskin, MD
1, Janet Owens-Grillo, PhD, MS
2, Elizabeth Thomas, MS
2, Kenneth M. Peters, MD
3, Eric S. Rovner, MD
4, Salim Mujais, MD
2.
1Tufts University School of Medicine, Boston, MA, USA2Sumitomo Pharma America, Inc., Marlborough, MA, USA3Oakland University William Beaumont School of Medicine, Rochester, MI, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA4Medical University of South Carolina, Charleston, SC, USA.
Can Anatomical Measurements on Preoperative Pelvic Magnetic Resonance Imaging Predict Postoperative Urinary Incontinence After Holmium Laser Enucleation of the Prostate?
Shayan Smani, BS
1, Amir I. Khan, MD
2, Ankur U. Choksi, MD
1, Benjamin H. Press, MD
1, Syed N. Rahman, MD
1, Christopher S. Hayden, MD
1, Mursal Gardezi, MD
1, Michael Jalfon, MD
1, Jason J. Lee, MD
1, Preston C. Sprenkle, MD
1, Daniel S. Kellner, MD
1.
1Yale University School of Medicine, New Haven, CT, USA2Vanderbilt University School of Medicine, Nashville, TN, USA.
Obesity Reawakens Prostatic Stem-like Features to Drive Prostate Volume Expansion and Attenuates 5ARI Effectiveness
Xingbo Long, M.D., Christina Sharkey, M.S., Yao Tang, M.S., Zongwei Wang, Ph.D., Aria F Olumi, M.D..
Beth Israel Deaconess Medical Center, Brookline, MA, USA.
Implementation of Electronic Consent Improves First Start
Olamide Olawoyin, MD, Shayan Smani, BSc, Ankur U. Choksi, MD, Marianne Passarelli, MD, Marianne Casilla-Lennon, MD.
Yale New Haven Health, New Haven, CT, USA.
National Analysis of Post-Procedural Urinary Incontinence Following Benign Prostatic Hyperplasia Treatments Using a Live Claims Database
Benjamin E. Rubin, BS
1,Jacob I. Bleau, BS
1, Davis C. Moore, MD
2, Curtis A. Plante, BS
1, Sarah Kohl, BS
1, Angelina Kuzina, BS
1, Nicholas Khoo, BS
1, Brian Irwin, MD
2, Mohammad Mohaghegh, MD
2, Richard T. Grunert, MD
2.
1University of Vermont Larner College of Medicine, Burlington, VT, USA2University of Vermont Medical Center, Burlington, VT, USA.
*3:30 pm - 4:00 pm
COFFEE BREAK
Grand Ballroom A+B
*4:00 pm - 4:30 pm
ROCK SOCIETY LECTURE: "Our pets: A parallel patient population that can advance the science of stone disease"
Grand Ballroom C+D+E
Speaker: Eva Furrow, VMD PhD
*4:30 pm - 5:30 pm
SOCIOECONOMIC SESSION I: The ABC's of private equity and how it is impacting medicine and urology
Grand Ballroom C+D+E
Panelists: Michael Curran, MD, Brian Kowal, MD, Veronica Triaca, MD and Sagar Phatak, MD
*5:30 pm - 6:00 pm
POINT COUNTERPOINT / PANEL:
Grand Ballroom C+D+E
Jelmyto "It's worth every penny"
Moderator: John Seigne, MD
Panelists:
PRO: Adam Feldmanv, MD vs. CON: Patrick A. Kenney, MD
*6:00 pm - 7:00 pm
WELCOME RECEPTION IN EXHIBIT HALL
Grand Ballroom A+B
FRIDAY, SEPTEMBER 5, 2025
*7:00 am - 8:00 am
BREAKFAST SYMPOSIUM Supported by Telix
Title: 68-Ga-PSMA-11 PET/CT Imaging for the Detection of Prostate Cancer
Speaker: Dr. Hanan Goldberg, MD
Grand Ballroom C+D+E
8:00 am - 10:30 am
CONCURRENT APP PROGRAMMING
Commonwealth Ballroom A+B
8:00 am - 10:00 am
POCUS Hands On Workshop sponsored by Samsung
Rus Korets, MD and Ryan Steinberg, MD
8:00 am - 9:00 am
Didactic lecture to cover the fundamentals and clinical applications
9:00 am - 10:00 am
Hands on workshop in small groups focused on:
- Becoming more facile with ultrasound equipment and image optimization
- Performing and interpreting ultrasound of the kidney.
- Performing and interpreting ultrasound of the bladder and prostate.
10:00 am - 10:30 am
Point Counterpoint: To DRE or not to DRE
Laura Pittenger, PA vs Michelle Lavery, NP
*8:00 am - 9:00 am
HOT TOPICS IN UROLOGY
Moderators: Jesse Sammon, DO and Rachel Moses, MD
Grand Ballroom C+D+E
Talk 1: Contemporary Management of Male SUI (ProAct)
Joshua Sterling, MD
Talk 2: Post Prostatectomy Testosterone use
Kevin Loughlin, MD
Talk 3: Suction URS
David Sobel, MD
Talk 4: Focal HIFU
Alexander Cole, MD
9:00 am - 10:30 am
SCIENTIFIC SESSION 4: Oncology II
Grand Ballroom C+D+E
5 minute presentation, 2 minute discussion)
Moderators: Jospeh Wagner, MD and Lawrence Dagrosa, MD
Radiation Cystitis Associated Patient Reported Outcomes and Urine Inflammatory Biomarkers Pre and Post Hyperbaric Oxygen Therapy
Ambrose Orr, MD
1, Richard Bellemare, MD
1, Daniel Mielcarz, PhD
2, Suwen Wu, MS
3, Janet Peacock, BS
3, Pamela Hannigan, RN
1, Lawrence Bornt, RN
1, William Bihrle, III, MD
1, Jay Buckey, Jr., MD
4, Rachel A. Moses, MD, MPH
1.
1Dartmouth Health Department of Surgery, Section of Urology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA2DartLab Dartmouth Cancer Center Geisel School of Medicine, Hanover, NH, USA3Geisel School of Medicine at Dartmouth College, Hanover, NH, USA4Dartmouth Health Department of Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Single-Port Robotic Partial Nephrectomy via Low-Anterior Access Is Safe and Feasible: Experience from a Single-Center Cohort
Guilherme Garcia Barros, MD
1, Nathaniel F. Hansen, MD
2,Muhieddine Labban, MD
2, Zhiyu (Jason) Qian, MD
2, Christopher P. Dall, MD
2, Jose Ignacio Nolazco, MD
2, Steven L. Chang, MD, MS
2, Timothy N. Clinton, MD
2.
1University of São Paulo, São Paulo, Brazil2Brigham and Women's Hospital, BOSTON, MA, USA.
TAR-200 monotherapy in patients with bacillus Calmette-Guérin-unresponsive high-risk non-muscle-invasive bladder cancer carcinoma in situ: 1-year durability and patient-reported outcomes from SunRISe-1
Joseph M. Jacob, MD
1, Félix Guerrero-Ramos, MD, PhD
2, Andrea Necchi, MD
3, Martin Bögemann, MD
4, Michiel S. Van der Heijden, MD, PhD
5, Daniel Zainfeld, MD
6, Philipp Spiegelhalder, MD
7, Giuseppe Simone, MD, PhD
8, Evanguelos Xylinas, MD
9, David Cahn, MD
10, Yair Lotan, MD
11,Katie S. Murray, DO
12, Takashi Kawahara, MD, PhD
13, Katharine Stromberg, PhD
14, Jason Martin, PhD
15, Abhijit Shukla, PhD
16, Kristi Bertzos, PhD
17, Shalaka Hampras, PhD
14, Hussein Sweiti, MD
18, Siamak Daneshmand, MD
19.
1Upstate Medical University, Syracuse, NY, USA2Hospital Universitario 12 de Octubre, Madrid, Spain3IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy4Münster University Hospital, Münster, Germany5Netherlands Cancer Institute, Amsterdam, Netherlands6Urology San Antonio, San Antonio, TX, USA7Urologie Neandertal, Gemeinschaftspraxis für Urologie, Mettmann, Germany8'Regina Elena' National Cancer Institute, Rome, Italy9Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France10Colorado Urology, Lakewood, CO, USA11UT Southwestern Medical Center, Dallas, TX, USA12NYU Langone Health, New York, NY, USA13Yokohama City University Medical Center, Yokohama, Japan14Johnson & Johnson, Raritan, NJ, USA15Johnson & Johnson, High Wycombe, United Kingdom16Johnson & Johnson, Lexington, MA, USA17Johnson & Johnson, Horsham, PA, USA18Johnson & Johnson, Spring House, PA, USA19University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
The Role of CRP in Cystectomy: Forecasting Future Complications
Adam Cole, MD
1, Randie White, MD
1, Raeann Dalton, DO
1, Connor Pelletier, BS
2, Emilie Platteter, BS
2, Evelyn James, MPH
1, Joshua Linscott, MD, PhD
3, Jeffrey Howard, MD, PhD
1, Stephen Ryan, MD
1, Matthew Hayn, MD
1, Jesse Sammon, DO
1.
1Maine Medical Center, Portland, ME, USA2University of New England, Portland, ME, USA3Moffitt Cancer Center, Tampa, FL, USA.
Long-term outcomes of treatment of low-grade upper tract urothelial carcinoma with UGN-101, a mitomycin reverse thermal gel
Joseph Brito, MD
1, Brian Hu, MD
2, Nir Kleinmann, MD
3, Jay D. Raman, MD
4, Hristos Kaimakliotis, MD
5, Alexander Sankin, MD
6, Nirmish Singla, MD
7, Andrew Meads, BS
8, Brent Burger, MSc, MBA
8, Sunil Raju, MBBS
8, Michael J. Louie, MD, MPH, MSc
8, Karim Chamie, MD
9, Alon Weizer, MD
10, Mark Schoenberg, MD, FACS
8.
1Yale School of Medicine, New London, CT, USA2Loma Linda University, Loma Linda, CA, USA3Sheba Medical Center, Ramat Gan, Israel4Penn State Health Milton S. Hershey Medical Center, Hershey, MD, USA5Indiana University School of Medicine, Indianapolis, IN, USA6Albert Einstein College of Medicine, Bronx, NY, USA7The Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA8UroGen Pharma, Princeton, NJ, USA9University of California Los Angeles (UCLA), Los Angeles, CA, USA10Division of Columbia University at Mount Sinai Medical Center, Miami Beach, FL, USA.
Rural-Urban Disparities in Access to Multiparametric MRI for the Workup of Elevated PSA in the United States from 2019-2023: A Medicare Claims Analysis
Nathaniel Fox Hansen, MD, MPH
1, Hanna Zurl, MD
2, Stephan Korn, MD
2, Jianyi Zhang, PhD, MS
2, Caroline Moore, MD
3, Quoc-Dien Trinh, MD
4, Alexander Cole, MD
1.
1Brigham and Women's Hospital, Boston, MA, USA2Center for Surgery and Public Health, Boston, MA, USA3University College London, London, United Kingdom4University of Pittsburgh, Pittsburgh, PA, USA.
Race-based Trends in Metastatic Prostate Cancer at Diagnosis from 2005 to 2020: The Racial Gap is Narrowing
Hanna Zurl, MD
1, Zhiyu Qian, MD
2, Klara K. Pohl, MD
1, Andrea Piccolini, MD
3, Stephan M. Korn, MD
3, Muhieddine Labban, ScD
2, Mansoo Cho, MS
3, Sean A. Fletcher, MD
4, Marianne Leitsmann, MD MHBA
5, Sascha Ahyai, MD
5, Quoc-Dien Trinh, MD MBA
6, Alexander P. Cole, MD
3.
1Center for Surgery and Public Health, Brigham and Women's Hospital and Medical University of Graz, Boston, MA, USA2Brigham and Women's Hospital, Boston, MA, USA3Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA4Johns Hopkins University School of Medicine, Baltimore, MD, USA5Medical University of Graz, Graz, Austria6University of Pittsburgh, Pittsburgh, PA, USA.
Trends in Prostate MRI Adoption Before Biopsy Among Commercially Insured Patients
Shayan Smani, BS
1, Rong Wang, PhD
2, Preston Sprenkle, MD
1, Cary P. Gross, MD
3, Xiaomei Ma, PhD
2, Michael Leapman, MD MHS
1.
1Department of Urology, Yale University School of Medicine, New Haven, CT, USA2Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT, USA3Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
A Machine Learning Approach for Predicting Prostate Cancer Gleason Grade Group at Radical Prostatectomy
Lampros Pantazis, MD
1, Hersh H. Bendre, MD
1, Madhur Nayan, MD, PhD
2, Constantine Velmahos, MD
1, Clemens An, BS
1, Alexandra Hunter, BA
1, Douglas M. Dahl, MD
1, Chin-Lee Wu, MD, PhD
1, Matthew Wszolek, MD
1, Keyan Salari, MD, PhD
1, Adam S. Feldman, MD, MPH
1.
1Massachusetts General Hospital, Boston, MA, USA,2New York University Medical Center, New York, NY, USA.
Can Surveillance Biopsy be Omitted in Active Surveillance for mpMRI-Negative Prostate Cancer?
Lampros Pantazis, MD, Hersh H. Bendre, MD, Aileen J. Feng, BA, Alexandra Hunter, BA, Neel Patel, MBBS, MPH, Douglas M. Dahl, MD, Matthew Wszolek, MD, Jason Efstathiou, MD, DPhil, Keyan Salari, MD, PhD, Adam S. Feldman, MD, MPH.
Massachusetts General Hospital, Boston, MA, USA.
Predicting Post-Prostatectomy Quality of Life: Machine Learning Models for Enhanced Patient-Centered Decision-Making
Zhiyu (Jason) Qian, MD
1, Stephan Korn, MD
1, Andrea Piccolini, MD
1, Pietro Brin, MD
1, Hanna Zurl, MD
1, Klara Pohl, MD
1, Alexander P. Cole, MD
1, Quoc-Dien Trinh, MD, MBA
2.
1Brigham and Women's Hospital, Boston, MA, USA2University of Pittsburgh, Pittsburgh, PA, USA.
Clinical Predictors of Incidental Prostate Cancer at the Time of Holmium Laser Enucleation of the Prostate
Jeffrey Carbonella, MD
1, Gabriela M. Diaz, MD
1, Julien DuBois, BS
1, Nishan Sohoni, MS
1, Aleksandra M. Golos, BS
1, Xiangyi Xi, PhD, MS
2, Daniel Kellner, MD
1.
1Yale School of Medicine, New Haven, CT, USA2Yale Center for Analytical Sciences, New Haven, CT, USA.
*10:30 am - 11:00 am
COFFEE BREAK
Grand Ballroom A+B
10:30 am - 11:30 am
CONCURRENT APP PROGRAMMING: Difficult Conversations
Susan Palmer, PA
Commonwealth Ballroom A+B
*11:00 - 11:30
SOCIOECONOMIC SESSION II: Current Paradigms of Care for Children with Differences of Sexual Development
Grand Ballroom C+D+E
Current Paradigms of Care for Children with Differences of Sexual Development
Anne Dudley, MD
*11:30 am - 11:40 am
PRESIDENTIAL ADDRESS
Grand Ballroom C+D+E
Vernon Pais, MD
*11:40 am - 12:20 pm
LEADBETTER LECTURE
Kidney Stone Formation and Obesity, Impact of the Disease and its Treatment on Stone Risk
Grand Ballroom C+D+E
Dean Assimos, MD
*12:20 pm - 12:30 pm
Joseph Dowd Award
Grand Ballroom C+D+E
*12:30 pm - 12:45 pm
SES Updates: Urology PAC
Grand Ballroom C+D+E
Art Tarantino, MD
*12:45 pm - 1:45 pm
LUNCH SYMPOSIUM: "DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment"
Supported by Sumitomo
Commonwealth Ballroom A+B
Speaker: Howard B Goldman MD FACS
LUNCH SYMPOSIUM: "Treatment Intensification with XTANDI (Enzalutamide) for Patients with Metastatic Castration-Sensitive Prostate Cancer & Nonmetastatic Castration-Sensitive Prostate Cancer with Biochemical Recurrence at High Risk for Metastasis"
Supported by Astellas/Pfizer
Grand Ballroom C+D+E
Speaker: Gordon Brown, DO, FACOS
1:45 pm - 2:15 pm
BUSINESS MEETING (Members Only)
Grand Ballroom C+D+E
1:45 pm - 4:30 pm
CONCURRENT APP PROGRAMMING
Commonwealth Ballroom A+B
1:45 pm - 2:05 pm
Pediatric Update
Courtney Anson, PA
2:05 pm - 2:25 pm
Neurogenic Bladder
Joel Lee, PA
2:25 pm - 2:45 pm
Overactive Bladder, advanced minimally invasive therapies
Tatiana Novokova, NP
2:45 pm - 3:05 pm
ED second and third line therapies
Craig Corey, NP
3:05 pm - 3:25 pm
Focal Therapies for prostate cancer
Katherine Dalia, PA
3:30 pm - 4:30 pm
HANDS ON SESSION: Self Defense for Health Care Providers
Otto Liebman, MD
2:15 pm - 3:45 pm
SCIENTIFIC SESSION V: Stones / Endourology
Grand Ballroom C+D+E
5 minute presentation, 2 minute discussion)
Moderators: Eric Katz, MD and Rus Korets, MD
Utility of Acute Care Urology (ACU) Practice Model in Streamlining Outpatient Stone Treatment
Akshay G. Reddy, MD, Octavia N. Devon, MD, Michelle Kim, MD, PhD, Jeffrey S. Lamont, MD, Marc D. Manganiello, MD.
Massachusetts General Hospital, Boston, MA, USA.
A Prospective Study of Steerable Ureteroscopic Renal Evacuation Using the Second-Generation CVAC Aspiration System: Results from the CLEARANCE Study
Brian Eisner, MD
1, Niramya Pathak, MD
2, Ravindra Sabnis, MD
2, Arvind Ganpule, MD
2, Abhishek Singh, MD
2, Abhijit Patil, MD
2, Rohan Bahtra, MD
2, Nishanth Shanthin, MD
2, Chaitya Shah, MD
2, Glenn Preminger, MD
3, Mahesh R. Desai, MD
2, Roger L. Sur, MD
4.
1MassGeneralBrigham Urology, Boston, MA, USA2Muljibhai Patel Urological Hospital, Nadiad, India3Duke University School of Medicine, Durham, NC, USA4University of California, San Diego, San Diego, CA, USA.
A Novel Electronic Health Record-Integrated Clinical Pathway for Nephrolithiasis: Development and Management Outcomes
Shayan Smani, BS, Soum D. Lokeshwar, MD MBA, Ankur U. Choksi, MD, Daniel Heacock, PA, Naga S. Kanaparthy, MD MPH, Devin M. Shaheen, NP, Meir Dashevsky, MD, Thomas Martin, MD, Dinesh Singh, MD, Piruz Motamedinia, MD, Rohit Sangal, MD MBA.
Yale University School of Medicine, New Haven, CT, USA.
Does artificial intelligence adhere to aua guidelines in the management of patients with ureteral and renal stones?
Sydney Look-Why, BA
1, Daniel Givner, MD
2, Bouyon Xiao, BS
1, David Wang, MD
2.
1Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA2Boston Medical Center, Boston, MA, USA.
Risk of Stone Formation with Use of Topiramate and Comparator Medications: A VigiBase Analysis
Jonathan J. Song, BA
1, James McAndrew Jones, III, MD
2, David S. Wang, MD
2, Daniel A. Wollin, MD MS
3.
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA2Boston Medical Center, Boston, MA, USA3Brigham and Women's Hospital, Boston, MA, USA.
Higher Frequency of Stone-Related Procedures in Patients with Neurogenic Bladder: A National Review Using a Live Claims Database
Jacob Bleau, B.S.
1, Benjamin Rubin, B.S.
1, Angelina Kuzina, B.S.
1, Sarah Kohl, B.S.
1, Nicholas Khoo, B.S.
1, Mohammad Mohaghegh, M.D, FRCSC
2, Richard Grunert, M.D.
2, Brian Irwin, M.D.
2.
1The Robert Larner, M.D. College of Medicine at the University of Vermont, Burlington, VT, USA2The University of Vermont Medical Center, Burlington, VT, USA.
Risk Factors for Kidney Stone Development in GLP-1RA Users
Sofia Maurina Di Scipio, BA
1, Shreya Thiagarajan, BS
2, Areeba Sadiq, MD
1.
1NYU Grossman Long Island, Mineola, NY, USA2University of Texas at Austin Dell Medical School, Austin, TX, USA.
Percutaneous Nephrostomy Tubes in Pregnancy: A Multi-Institutional Experience
Analiese Ionson, MD
1,Grayden S. Cook, MD
2, Madison Lyon, MD
1, Daniel Wollin, MD, MPH
2, Smita De, MD
1.
1Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA2Mass General Brigham, Boston, MA, USA.
Comparison of Opioid Requirements after Peripheral Nerve Block in Standard and mini Percutaneous Nephrolithotomy
Olamide Olawoyin, MD, Ankur U. Choksi, MD, Mursal Gardezi, MD, Jinlei Li, MD, PhD, Piruz Motamedina, MD.
Yale New Haven Health, NEW HAVEN, CT, USA.
*3:45 pm - 4:15 pm
COFFEE BREAK
Grand Ballroom A+B
*4:15 pm - 4:45 pm
SUO GUEST LECTURE
Using an implantable microdevice to test drug responses in patients undergoing cystectomy
Grand Ballroom C+D+E
Matthew Mossanen, MD
*4:45 pm - 5:15 pm
YOUNG UROLOGIST FORUM: Building Your Brand
Grand Ballroom C+D+E
Courtney Rowe, MD
*5:15 pm - 6:15 pm
WOMEN IN UROLOGY SESSION: Career Advancement: Promotions and Transitions
Grand Ballroom C+D+E
Moderator: Simone Thavaseelan, MD
Panelists: E. Ann Gormley, MD Jennifer Yates, MD, and Laura Leddy, MD
*7:00 pm - 10:00 pm
PRESIDENTIAL CELEBRATION at Legal Seafood Harborside, 3rd
Floor Rooftop
SATURDAY, SEPTEMBER 6, 2025
*7:00 am - 8:00 am
BREAKFAST SYMPOSIUM Supported by Johnson & Johnson: "Head-to-head overall survival data in mCSPC: A review of real-world evidence"
Grand Ballroom C+D+E
Speaker: Gordon Brown, DO, FACOS
8:00 am - 9:30 am
SCIENTIFIC SESSION VI: Oncology III
Grand Ballroom C+D+E
5 minute presentation, 2 minute discussion)
Moderators: Samuel Eaton, MD and Andrea Sorcini, MD
New Generation RNA Sequencing of Urethral Cancer Compared with Benign Urethral Tissue: Implications for Diagnostic and Future Research Advancements
Nickolas Kinachtchouk, MD, MBA
1, Samantha Freeman, MD
1, Rachael Gotlieb, MD
1, Kailey Hooper, BS
1, Travis Sullivan, MS
1, Eric Burks, MD
2, Kimberly Rieger-Christ, PhD
1, Alex J. Vanni, MD
1.
1Lahey Hospital, Burlington, MA, USA2Boston Medical Center, Boston, MA, USA.
Feasibility of and Adherence to a Pilot Prehabilitation Program For Bladder Cancer Patients undergoing Radical Cystectomy
Nnamdi Onochie, Jr., B.S.
1, Rebekah Wilson, PhD
2, Amber Normann, MS
2, Amanda J. Reich, PhD, MPH
1, Catherine J. Quinn, PA-C
1, Timothy N. Clinton, MD
1, Mark A. Preston, MD, MPH
1, Graeme S. Steele, MD
1, Adam S. Kibel, MD
1, Christina M. Dieli-Conwright, PhD, MPH
2,Matthew Mossanen, MD, MPH
1.
1Brigham and Women's hospital, Boston, MA, USA2Dana Farber Cancer Institute, Boston, MA, USA.
Encore Durability Results From BOND-003 Cohort C-Phase 3, Single-Arm Study of Intravesical Cretostimogene Grenadenorepvec for High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma In Situ
Mark Tyson, MD, MPH
1, Edward M. Uchio, MD
2, Jong-Kil Nam, MD
3, Shreyas Joshi, MD
4,Trinity J. Bivalacqua, MD, MPH
5, Gary Steinberg, MD
6, Hiroshi Kitamura, MD
7, Ben Tran, MBBS
8, Roger Li, MD
9.
1Mayo Clinic, Phoenix, AZ, USA2University of California Irvine, Irvine, CA, USA3Busan National University Yangsan Hospital, Yangsan, Korea, Democratic People's Republic of4Emory University School of Medicine, Atlanta, GA, USA5University of Pennsylvania, Philadelphia, PA, USA6Rush University Medical Center, Chicago, IL, USA7University of Toyama, Toyama, Japan8Peter MacCallum Cancer Centre, Melbourne, Australia9H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Duration of response (DoR) following treatment with UGN-102 in patients with recurrent, low-grade, intermediate-risk, non-muscle invasive, bladder cancer: 18-month DoR data from the phase 3 ENVISION trial
Sandip M. Prasad, MD, MPhil
1, Dimitar Shishkov, MD
2, Nikola V. Mihaylov, MD
2, Alexandre Khuskivadze, MD
3, Pencho Genov, MD, PhD
4, Vasyl Terzi, MD
5, Max Kates, MD
6,William C. Huang, MD
7, Michael J. Louie, MD
8, Sunil Raju, MBBS
8, Brent Burger, MSc, MBA
8, Andrew Meads, BS
8, Mark Schoenberg, MD
9.
1Morristown Medical Center/Atlantic Health System and Garden State Urology, Morristown, NJ, USA2University Multiprofile Hospital for Active Treatment, Plovdiv, Bulgaria3Georgia Israel Joint Clinic Gidmedi, Tbilisi, Georgia4University Multiprofile Hospital for Active Treatment Kanev, Ruse, Bulgaria5Multiprofile Hospital for Active Treatment Varna, Military Medical Academy, Varna, Bulgaria6Johns Hopkins Medicine, Baltimore, MD, USA7NYU Langone Urology Associates, New York, NY, USA8UroGen Pharma, Princeton, NJ, USA9UroGen Pharma, Princeton, NJ, USA; and The Department of Urology, Montefiore Medical Center: Einstein Campus, Bronx, NY, USA.
Dynamic Prediction of Recurrence and Progression Risk in Non-Muscle Invasive Bladder Cancer Using Conditional Survival: A SEER-Medicare Analysis
Chia-Chen Chang, MS
1, Agustin Perez-Londono, MD
2, Sumedh Kaul, MS
2, Aaron Fleisham, MD
2, Simon Kim, MD
3, Aria Olumi, MD
2, Peter Chang, MD, MPH
2, Andrew Wagner, MD
2, Boris Gershman, MD
2.
1Georgetown University, Washington, MA, USA2Beth Israel Deaconess Medical Center, Boston, MA, USA3University of Colorado Anschutz Medical Center, Aurora, CO, USA.
The Cost of Complications: How Socioeconomic Status Shapes Radical Cystectomy Outcomes
Adam Cole, MD
1, Connor Pelletier, BS
1, Emilie Platteter, BS
2, Randie White, MD
1, Evelyn James, MPH
1, Joshua Linscott, MD, PhD
3, Jeffrey Howard, MD, PhD
1, Stephen Ryan, MD
1, Matthew Hayn, MD
1, Jesse Sammon, DO
1.
1Maine Medical Center, Portland, ME, USA2University of New England, Portland, ME, USA3Moffitt Cancer Center, Tampa, FL, USA.
Is a 6 week Waiting Period Necessary? Challenging Historic Dogma on Timing of BCG Treatment and Vaccine Administration
Philip Olson, MD
1, Jonathan Saidon, BS
2, Ilene Staff, PhD
2, Kevin Pinto, BS
2, Tara McLaughlin, PhD
2, Laura Olivo Valentin, BS
2, Joseph Tortora, MS
2, Ulysses Wu, MD
2, Anoop Meraney, MD
2.
1UConn Health, Farmington, CT, USA2Hartford Healthcare, Hartford, CT, USA.
Improved recurrence-free survival following implementation of a 3d tumor model fusion pipeline for renal mass ablation
Raymond Che, MPH
1, Richard Glebocki, ScB
1, Aaron Seto, ScB, AB
1, Borivoj Golijanin, MD
1, Brian Jay, MD
2, Kamil Malshy, MD
1, Emily Barry, MD
1, Scott Collins, RT(R)(CT)
2, Aaron Maxwell, MD
2, Gregory Dubel, MD
2, Sari Khaleel, MD
1, Dragan Golijanin, MD
1.
1The Minimally Invasive Urology Institute at the Miriam Hospital, Brown University Health, Legoretta Cancer Center, Warren Alpert Medical School of Brown University, Providence, RI, USA2Brown University Health, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Safety of Transurethral Resection of Bladder Tumor in Octogenarians: A NSQIP Analysis
Jonathan J. Song, BA
1, Maya T. Zhou, BS
1, James McAndrew Jones, III, MD
2, Samuel Z. Lee, BA
1, Mark H. Katz, MD
2, David S. Wang, MD
2.
1Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA2Boston Medical Center, Boston, MA, USA.
Baseline renal function influences overall survival in patients undergoing renal mass ablation of small renal masses
Borivoj Golijanin, MD
1, Raymond Che, BSc
1, Richard Glebocki, BSc
1, Kamil Malshy, MD
1, Aaron Seto, BSc
1, Brian Jay, MD
2, Emily Barry, MD
1, Scott Collins, RT(R)(CT)
2, Aaron Maxwell, MD
2, Gregory Dubel, MD
2, Sari Khaleel, MD
1, Dragan Golijanin, MD
1.
1Minimally Invasive Urology Institute, Brown University Health, Warren Alpert Medical School of Brown University, Providence, RI, USA2Brown University Health, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Pre-Treatment Predictors of Pathological Failure at One Year Following Focal Therapy for Localized Prostate Cancer
Nethusan Sivanesan, BS, Gabriela M. Diaz, MD, Xiwen Zhao, MPH, Peter S. Palencia, BS, Wei S. Tan, MD, PhD, Preston C. Sprenkle, MD.
Yale School of Medicine, New Haven, NC, USA.
Mevrometostat, an enhancer of zeste homolog 2 (EZH2) inhibitor, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC): A randomized dose-expansion study
Michael Thomas Schweizer, MD
1, Mariona Calvo, MD
2, Victor Moreno, MD, PhD
3, Begoña Mellado, MD, PhD
4, Daniel Castellano, MD
5, Alexander I. Spira, MD
6, Qiang Wei, MD
7, Joan Carles, MD, PhD
8, Benjamin Garmezy, MD
9, Cheol Kwak, MD, PhD
10, Iwona ugowska, MD, PhD
11, Konstantin Penkov, MD
12, Neal D. Shore, MD
13, Li Liu, PhD
14, Rajendar K. Mittapalli, PhD
14, Jessica Tougias, PhD
15, Claudia Andreu-Vieyra, PhD
16, Neelesh Soman, MD, PhD
17, Teresa Alonso Gordoa, MD
18.
1Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA2Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain3START Madrid-FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain4Hospital Clínic i Provincial de Barcelona, Barcelona, Spain5Hospital Universitario 12 de Octubre, Madrid, Spain6Virginia Cancer Specialists PC, Fairfax, VA, USA7Department of Urology, West China Hospital of Sichuan University, Chengdu, China8Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain9Sarah Cannon Research Institute, Nashville, TN, USA10Department of Urology, Seoul National University Hospital, Seoul, Korea, Republic of11Early Phase Clinical Trials Department, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland12General Department, Private Medical Institution "Euromedservice", St Petersburg, Russian Federation13Carolina Urologic Research Center, Myrtle Beach, SC, USA14Pfizer Inc., San Diego, CA, USA15Pfizer Inc., New York, NY, USA16Pfizer Inc., Collegeville, PA, USA17Pfizer Inc., Los Angeles, CA, USA18Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
8:00 am - 9:30 am
CONCURRENT POSTER SESSION IV: Benign
Commonwealth Ballroom C
(30 min viewing, 2-min presentation, 2-min discussion)
Moderators: Linda Ng, MD and Simone Thavaseelan, MD
Rat Model for the Study of the Effect of Peroneal Nerve Stimulation on Bladder Function
Reine Kanaan, PhD
1, Hunter R. Myers, MD
2, Lilla Erdos, B.Sc.
2, Jan Krhut, MD, PhD
3, Benjamin R. King, MD
2, Peter Zvara, MD, PhD
1.
1University of Southern Denmark, Odense, Denmark2University of Vermont, Burlington, VT, USA3Ostrava University, Ostrava, Czech Republic.
Improving Postoperative Urologic Patient Care: Encouraging Language Diversity Through Implementation of Language Concordant Discharge Instructions
Daniela Diaz Rubayo, MD,Justin V. Nguyen, BS, Katherine Merport, BA, Jennifer E. Fantasia, MD.
UMass Chan Medical School, Worcester, MA, USA.
Urodynamic Outcomes Following Photovaporization of the Prostate for Benign Prostatic Hyperplasia: Diminished Detrusor Voiding Pressure Preserves Function After Surgery
Jonathan S. Kim, Medical Student
1, Parker J. Simpson, Independent Researcher
2, Chaimaa M. Hossaini, Independent Researcher
2, Louis S. Liou, MD, PhD
3.
1Drexel University College of Medicine, Philadelphia, PA, USA2AOA Urological Associates, Boston, MA, USA3Emerson Hospital, Concord, MA, USA.
Outcomes of Ureteral Injuries during Abdominopelvic Surgery With and Without Ureteral Catheterization
Peter S. Palencia, BS, Michael S. Leapman, MD, MSHS, Jaime A. Cavallo, MD, MSHS.
Department of Urology, Yale School of Medicine, New Haven, CT, USA.
Multicenter Evaluation on the Use of Down-Sized Cylinders in Penile Prosthesis Surgery
Remington Lim, MD
1, Jeffrey Lee, BA
2, Elia Abou Chawareb, MD
2, Muhammad Hammad, MD
2, Daniar Osmonov, MD
3, Hossein Sadeghi-Nejad, MD
4, Arthur Burnett, MD
5, Ian Pearce, MD
6, Aaron Lentz, MD
7, Kelli Gross, MD
8, James Hotaling, MD
9, Maxime Sempels, MD
10, Sung Hun Park, MD
11, Koenraad van Renterghem, Dr. med.
12, Georgios Hatzichristodoulou, Dr. med.
13, Robert Andrianne, MD
10, James Jones, MD
14, Tung-Chin Hsieh, MD
15, J Nicholas Warner, MD
16, Matthew Ziegelmann, MD
16, Paul Perito, MD
17, Jay Simhan, MD
18, Faysal Yafi, MD
2, Martin Gross, MD
1, David Barham, MD
2.
1Dartmouth Hitchcock, LEBANON, NH, USA2University of California Irvine, Orange, CA, USA3University Hospital Schleswig Holstein, Campus Kiel, Germany4Hackensack University Medical Center, Hackensack, NJ, USA5Johns Hopkins University, Baltimore, MD, USA6Manchester Andrology Centre, Manchester, United Kingdom7Duke University, Durham, NC, USA8University of Utah, Salt Lakek City, UT, USA9University of Utah, Salt Lake City, UT, USA10University Hospital of Liège, Liège, Belgium11Sewum Prosthetic Urology, Seoul, Korea, Democratic People's Republic of12Jessa Hospital, Hasselt, Belgium13'Martha-Maria' Hospital, Nuremberg, Germany14Boston Medical Center, Boston, MA, USA15University of California San Diego, La Jolla, CA, USA16Mayo Clinic, Rochester, MN, USA17Perito Urology, Coral Gables, FL, USA18Fox Chase, Philadelphia, PA, USA.
Body Mass Index and Complication Profiles in Patients Undergoing Inflatable Penile Prosthesis Placement: A Large Multi-Institutional Study
Stephen Harrington, M.D.
1, Muhammed Hammad, M.D.
2, David Barham, M.D.
3, Robert Andrianne, M.D., Ph.D.
4, Hossein Sadeghi-Nejad, M.D.
5, Kelli Gross, M.D.
6, Georgios Hatzichristodoulou, M.D.
7, James Hotaling, M.D.
6, Tung-Chin Hsieh, M.D.
8, Aaron Lentz, M.D.
9, Vaibhav Modgil, BM, MSc
10, Daniar Osmonov, M.D.
11, Sung Hun Park, M.D.
12, Faysal Yafi, M.D.
2, Paul Perito, M.D.
13, Jay Simhan, M.D.
14, Koenraad van Renterghem, M.D., Ph.D.
15, Ambrose Orr, M.D.
1, Vikram Lyall, M.D.
1, Richard Bellemare, M.D.
1, Remington Lim, M.D.
1, Nicholas Moll, M.D.
1, Martin Gross, M.D.
1.
1Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA2Department of Urology, University of California, Irvine, Orange, CA, USA3Department of Surgery, Urology Section, Brooke Army Medical Center, San Antonio, TX, USA4Department of Urology, University Hospital of Liège, Liège, Belgium5Department of Urology, New York University, New York, NY, USA6Department of Surgery, University of Utah, Salt Lake City, UT, USA7Department of Urology, Martha-Maria Hospital Nuremburg, Nuremburg, Germany8Department of Urology, University of California, San Diego, CA, USA9Department of Urology, Duke University, Durham, NC, USA10Manchester Andrology Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom11Department of Urology, University Hospital Schleswig-Holstein, Kiel, Germany12Sewum Prosthetic Urology, Seoul, Korea, Republic of13Perito Urology, Coral Gables, FL, USA14Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA15Department of Urology, Jessa Hospital, Hasselt, Belgium.
Infection Rates with Intraoperative Dilute Chlorhexidine Gluconate in Hydrophilic Coated Inflatable Penile Implants: Initial Results from a Large Multi-Institutional Cohort
Richard Hans Bellemare, MD
1, Samuel Ivan, MD
2, Muhammed AM Hammad, MBBCh
3, Elia Abou Chawareb, MD
3, Faysal A. Yafi, MD
3, Helen L. Bernie, MD
4, Aaron C. Lentz, MD
5, Paul Perito, MD
6, Charles Welliver, MD
7, Paul H. Chung, MD
8, Tung-Chin Hsieh, MD
9, Allen F. Morey, MD
10, Sevann Helo, MD
11, Matt J. Ziegelmann, MD
11, Jonathan N. Warner, MD
11, Tobias S. Kohler, MD
11, Hossein Sadeghi-Nejad, MD
12, Sarah Vij, MD
13, Petar Bajic, MD
14, Kelli Gross, MD
15, James Hotaling, MD
15, Martin S. Gross, MD
1, Jay Simhan, MD
2.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA2Fox Chase Cancer Center, Philadelphia, PA, USA3University of California, Irvine, Orange, CA, USA4Indiana University, Indianapolis, IN, USA5Duke University, Raleigh, NC, USA6Perito Urology, Coral Gables, FL, USA7Albany Medical Center, Albany, NY, USA8Jefferson Health, Philadelphia, PA, USA9University of California, San Diego, La Jolla, CA, USA10Urology Clinics of North Texas, McKinney, TX, USA11Mayo Clinic, Rochester, MN, USA12New York University, New York, NY, USA13University of Texas, Austin, Austin, TX, USA14Cleveland Clinic, Cleveland, OH, USA15University of Utah, Salt Lake City, UT, USA.
Decoding Applicant Discourse: Analyzing Social Media Discussions Around Urology Match Preference Signaling
Cedrick B. Chiu, BS,Katherine Merport, BA, Brielle Barclay-Rochefort, DPT, Luke Maietta, BA, Xinyue C. Tan, MD, Jennifer Fantasia, MD, Ashley Alford, MD.
UMass Chan Medical School, Worcester, MA, USA.
Does Peripheral Nerve Block prior to mini Percutaneous Nephrolithotomy Impact Opioid Requirements?
Ankur Ushir Choksi, MD
1, Olamide Olawoyin, MD
1, Mursal Gardezi, MD
1, Clark Judge, MD
2, Ganesh Sanekommu, MD
1, Jinlei Li, MD
1, Piruz Motamedinia, MD
1.
1Yale School of Medicine, New Haven, CT, USA2MaineHealth, Portland, ME, USA.
Preoperative and Perioperative Predictors of Adverse Patient Outcomes after Thulium Laser Enucleation of the Prostate
Daniel Sanford, MD
1, Suhas Penukonda, MD
1, Henrik Hector, BS
1, Anna Ochsner, MD
1, Raymond Chiang, BS ScM
1, Jarrett Noakes, BS
1, Joshua Ray Tanzer, PhD
2, Taylor Braunagel, MS
1, Samuel Eaton, MD
1, Samuel Eaton, MD
1.
1Division of Urology, Warren Alpert Medical School of Brown University, Providence, RI, USA2Brown University Health Biostatistics, Epidemiology, Research Design, Informatics, Providence, RI, USA.
Characterizing Kidney Stone Episodes by GLP-1RA Medication in GLP-1RA Users
Sofia Maurina Di Scipio, BA
1, Shreya Thiagarajan, BS
2, Areeba Sadiq, MD
1.
1NYU Grossman Long Island, Mineola, NY, USA,2University of Texas at Austin Dell Medical School, Austin, TX, USA.
*9:30 am - 10:00 am
COFFEE BREAK
Grand Ballroom A+B
*10:00 AM - 10:30 AM
STATE OF THE ART LECTURE II: Shifting Strategies in High Risk Non Muscle Invasive Bladder Cancer
Grand Ballroom C+D+E
Max Kates, MD
*10:30 AM - 11:15 AM
GUEST SPEAKER: "Practical pediatric urology for the general urologist"
Grand Ballroom C+D+E
Duncan Morhardt, MD
*11:15 AM - 11:30 AM
SECTION HISTORY UPDATE + PRESENTATIONS
Grand Ballroom C+D+E
Jen Yates, MD
Presentation 1: The Paradoxical History of Surgical Sterilization
Olamide Olawoyin, MD1, Ankur U. Choksi, MD1, Olaide Olawoyin, BSc2, Marianne Casilla-Lennon, MD1.
1Yale New Haven Health, NEW HAVEN, CT, USA, 2Western New England, Springfield, MA, USA.
Presentation 2: The Life and Legacy of Sir P.J. Freyer and the Evolution of Prostate Surgery
Shayan Smani, BS, Soum D. Lokeshwar, MD MBA, Nishan Sohoni, BS, Daniel S. Kellner, MD, Michael S. Leapman, MD MHS.
Yale University School of Medicine, New Haven, CT, USA.
11:30 am - 12:30 pm
SCIENTIFIC SESSION VII: Infertility, Sexual Dysfunction and Men's Health / BPH
Grand Ballroom C+D+E
5 minute presentation, 2 minute discussion)
Moderators: Katherine Rotker, MD and Martin Gross, MD
Contemporary Findings Regarding the Efficacy and Safety of the "Drain and Retain" Maneuver for Urologic Prosthetic Reservoirs During Inflatable Penile Prosthesis Revision Surgery
Ambrose Orr, MD
1, Thairo A. Pereira, MD
2, Jacob Rust, MD
2, Jacob Good, MD
2, Stephen Harrington, MD
1, Peter J. Arnold, MD
2, Thomas Alvermann, MD
3, Remington Lim, MD
1, Nicholas Moll, MD
1, David Barham, MD
4, Christabel Egemba, MD
5, Richard Bellemare, MD
1, Martin Gross, MD
1, Muhammed Hammad, MD
6, Mike Hseih, MD
7, Alex Huynh, MD
8, Aaron Lentz, MD
8, Brent Nose, MD
8, Jay Simhan, MD
9, Faysal Yafi, MD
6, Bernie Helen, MD
2.
1Dartmouth Hitchcock Medical Center, Lebanon, NH, USA2Indiana University, Indianapolis, IN, USA3Geisel School of Medicine at Dartmouth College, Hanover, NH, USA4Brooke Army Medical Center, Fort Sam Houston, TX, USA5University of Miami Miller School of Medicine, Miami, FL, USA6University of California, Irvine, Irvine, CA, USA7University of California, San Diego, San Diego, CA, USA8Duke University, Durham, NC, USA9Fox Chase Cancer Center, Philadelphia, PA, USA.
The Price of Coverage: Insurance Disparities in Testicular Torsion Outcomes Across Ten Years of Statewide Data
Loren J. Smith, M.D.
1, Jacqueline Klepinger, B.S.
2, Evelyn James, B.S., M.P.H.
1, Lily C. Wang, M.D., Ph.D.
1.
1MaineHealth Maine Medical Center, Urology, Portland, ME, USA2University of New England, College of Osteopathic Medicine, Biddeford, ME, USA.
The Impact of "Open" vs. "Closed" Vasectomy Technique on Rates of Azoospermia at First Post-Vasectomy Semen Analysis
Scott D. Matson, MD
1, Sonam Saxena, BS
2, Daniel Nolte, MS
3, Stacey A. Kenfield, ScD
4, Julie Gonzales, HS
3, David Shin, MD
2, James F. Smith, MD
4.
1St. Francis Hospital and Medical Center, Hartford, CT, USA2Hackensack University Medical Center, Hackensack, NJ, USA3Fellow Health, San Leandro, CA, USA4Dept of Urology, UCSF, San Francisco, CA, USA.
The Relationship between Age, Ejaculatory Frequency, Waiting Time to Post-Vasectomy Semen Analysis, and Clearance Rate
Scott Daniel Matson, MD
1, Sonam Saxena, BS
2, Daniel Nolte, MS
3, Stacey A. Kenfield, ScD
4, Julie Gonzales, HS
3, David Shin, MD
2, James F. Smith, MD
4.
1St. Francis Hospital and Medical Center, Hartford, CT, USA2Hackensack University Medical Center, Hackensack, NJ, USA3Fellow Health, San Leandro, CA, USA4Dept of Urology, UCSF, San Francisco, CA, USA.
IPP Infection Rates with 0.05% Chlorhexidine Gluconate (Irrisept®) Differ by Device Manufacturer: Initial Results from a Large Multi-Institutional Cohort
S Ivan, MD
1, Muhammed Hammad, MD
2, Elia Chawareb, md
3, Faysal Yafi, MD
3, Thairo Pereira, MD
4, Helen Bernie, MD
4, Stephen Harrington, MD
5, Richard Bellemare, MD
5,Ambrose Orr, MD
5, Nicholas Moll, MD
5, Aaron Lentz, MD
6, Alfredo Suarez-Sarmiento, MD
7, Paul Perito, MD
7, Tung-Chin Hsieh, MD
8, Matthew Ziegelmann, MD
9, Martin Gross, MD
5, Jay Simhan, MD
1.
1Fox Chase Cancer Center, Philadelphia, PA, USA2University of California, Irvine, Irvine, IN, USA3University of California, Irvine, Irvine, CA, USA4Indiana University, Indianapolis, IN, USA5Dartmouth Hitchcock Medical Center, Lebanon, NH, USA6Duke University, Durham, NC, USA7Perito Urology, Coral Gables, FL, USA8University of California, San Diego, San Diego, CA, USA9Mayo Clinic, Rochester, MN, USA.
Compliance with Post Vasectomy Semen Analysis: Comparison of in office fresh testing with scheduled office visit vs. fresh laboratory drop off alone
Katrina Jackson, BS
1, Brooke Harnisch, MD
2, Stanton Honig, MD
3, Ankur Choksi, MD
3.
1University of Connecticut, farmington, CT, USA2UConn Health, Farmington, CT, USA3Yale Medicine, New Haven, CT, USA.
Preference Signaling During the 2025 Urology Residency Match: Applicant and Program Director Perspectives
Ellen M. Cahill, MD, Aleksandra Golos, BS, Olamide Olawoyin, MD, Ankur U. Choksi, MD, Piruz Motamedinia, MD, Joshua Sterling, MD, MSc, Marianne Casilla-Lennon, MD.
Yale University School of Medicine, Department of Urology, New Haven, CT, USA.
Virtual versus In-person Interviews: Applicant and Program Director Attitudes during the 2025 Urology Match
Ellen M. Cahill, MD, Aleksandra Golos, BS, Olamide Olawoyin, MD, Ankur U. Choksi, MD, Piruz Motamedinia, MD, Joshua Sterling, MD, MSc, Marianne Casilla-Lennon, MD.
Yale University School of Medicine, Department of Urology, New Haven, CT, USA.
11:30 am - 12:30 pm
CONCURRENT VIDEO ABSTRACT SESSION
Commonwealth Ballroom A+B
5 minute video, 5 minute discussion)
Moderators: Matt Mossanen, MD and Boris Gershman, MD
Robotic Assisted Retroperitoneal Sarcoma Resection with Left Renal Vein Reconstruction With Bovine Pericardium
Ankur Ushir Choksi, MD, Joseph Black, Adam Nolte, David Mahvi, Umut Sarpel, Peter Chang, Andrew Wagner.
Beth Israel Deaconess Medical Center, New Haven, CT, USA.
Princess Mini-Holep: A Novel Adaptation of the 21 Fr. Resectoscope
Agustin Perez-Londono, MD., Andrew Williams, Ruslan Korets, MD.
Beth Israel Deaconess Medical Center, Boston MA, MA, USA.
One Stage Metoidioplasty with De-epithelialized Labia Minora Flap Urethral Reconstruction
Benjamin Green, MD, Marissa Kent, MD.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
Penile Prosthesis Placement After Phalloplasty
Nathaniel Fox Hansen, MD, MPH, Andrew Shin, Devin O'Brien-Coon, MD, William Boysen, MD.
Brigham and Women's Hospital, Boston, MA, USA.
Single Port Sees All: The Curious Case of the Blind-Ending UPJ and UVJ
Tracy R. Cherian, MD, Daniela Diaz Rubayo, MD, Gregory Kunkel, MD, Ashley Alford, MD.
U Mass Chan School of Medicine, Worcester, MA, USA.
Open Retroperitoneal Lymph Node Dissection With Bulky Teratoma
Christopher J. Magnani, MD MS MPhil, Timothy N. Clinton, MD.
Brigham and Women's Hospital, Boston, MA, USA.
